Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer. This report contains market size and forecasts of Lung Cancer Liquid Biopsy in Global, including the following market information: Global Lung Cancer Liquid Biopsy Market Revenue, 2017-2022, 2023-2028, ($ millions) Global top five companies in 2021 (%) The global Lung Cancer Liquid Biopsy market was valued at 438 million in 2021 and is projected to reach US$ 1056.2 million by 2028, at a CAGR of 13.4% during the forecast period. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. CTCs Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of Lung Cancer Liquid Biopsy include Biocept, Exosome Diagnostics, F. Hoffmann-La Roche, Qiagen, Accuragen, Agena Bioscience, Bard1 and Bgi, etc. In 2021, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lung Cancer Liquid Biopsy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Lung Cancer Liquid Biopsy Market, by Type, 2017-2022, 2023-2028 ($ millions) Global Lung Cancer Liquid Biopsy Market Segment Percentages, by Type, 2021 (%) CTCs CtDNA Exosomes And RNA Others Global Lung Cancer Liquid Biopsy Market, by Application, 2017-2022, 2023-2028 ($ millions) Global Lung Cancer Liquid Biopsy Market Segment Percentages, by Application, 2021 (%) Clinics Hospitals Physicians' Office Laboratories Global Lung Cancer Liquid Biopsy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) Global Lung Cancer Liquid Biopsy Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Lung Cancer Liquid Biopsy revenues in global market, 2017-2022 (estimated), ($ millions) Key companies Lung Cancer Liquid Biopsy revenues share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: Biocept Exosome Diagnostics F. Hoffmann-La Roche Qiagen Accuragen Agena Bioscience Bard1 Bgi
1 Introduction to Research & Analysis Reports 1.1 Lung Cancer Liquid Biopsy Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Lung Cancer Liquid Biopsy Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process
